elmiron® tolerability
  • Adverse events reported with elmiron® treatment were comparable to those reported under treatment with placebo in regards to quality and quantity1
  • The most common adverse events reported in clinical studies are headache, dizziness and gastrointestinal events1

Common (≥1/100 to <1/10) adverse events in SPC:1

Infections and infestations Infections, influenza
Nervous system disorders Headache, dizziness
Gastrointestinal disorders Nausea, diarrhoea, dyspepsia, abdominal pain, abdomen enlarged, rectal haemorrhage
Skin and subcutaneous tissue disorders Peripheral oedema, alopecia
Musculoskeletal and connective tissue disorders Back pain
Renal and urinary disorders Urinary frequency
General disorders and administration site conditions Asthenia, pelvic pain

Should you require more information regarding safety considerations, click here

  1. elmiron® 100 mg hard capsules, Summary of Product Characteristics, Consilient Health Ltd.